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to Detecting Gene-Gene Interactions
in Genome-wide Case-Control Studies
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and Weichuan Yu1,*
Gene-gene interactions have long been recognized to be fundamentally important for understanding genetic causes of complex disease
traits. At present, identifying gene-gene interactions from genome-wide case-control studies is computationally and methodologically
challenging. In this paper, we introduce a simple but powerful method, named ‘‘BOolean Operation-based Screening and Testing’’
(BOOST). For the discovery of unknown gene-gene interactions that underlie complex diseases, BOOST allows examination of all pair-
wise interactions in genome-wide case-control studies in a remarkably fast manner. We have carried out interaction analyses on seven
data sets from theWellcome Trust Case Control Consortium (WTCCC). Each analysis took less than 60 hr to completely evaluate all pairs
of roughly 360,000 SNPs on a standard 3.0 GHz desktop with 4G memory running the Windows XP system. The interaction patterns
identified from the type 1 diabetes data set display significant difference from those identified from the rheumatoid arthritis data set,
although both data sets share a very similar hit region in the WTCCC report. BOOST has also identified some disease-associated inter-
actions between genes in the major histocompatibility complex region in the type 1 diabetes data set. We believe that our method can
serve as a computationally and statistically useful tool in the coming era of large-scale interactionmapping in genome-wide case-control
studies.Introduction
Genome-wide case-control studies use high-throughput
genotyping technologies to assay hundreds of thousands
of SNPs and relate them to clinical conditions or measur-
able traits. To understand underlying causes of complex
disease traits, it is often necessary to consider joint genetic
effects (epistasis) across the whole genome. The concept of
epistasis1 was introduced around 100 years ago. It is
generally defined as interactions among different genes.
Recently, Phillips2 highlighted the essential role of gene-
gene interactions in the structure and evolution of genetic
systems. Three terminologies are used to describe gene-
gene interactions:
d Functional epistasis is a functional description that
addresses the molecular interactions.
d Compositional epistasis, originally defined by Bate-
son,1 is referred to as the blocking of one allelic effect
by another allele at a different locus.
d Statistical epistasis, attributed to Fisher,3 is defined as
the statistical deviation from the additive effects of
two loci on the phenotype.
The existence of epistasis has been widely accepted as an
important contributor to genetic variation in complex
diseases such as asthma, cancer, diabetes, hypertension,
and obesity.4 As a matter of fact, many researchers believe1Department of Electronic and Computer Engineering, The Hong Kong Un
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The Americanthat it is critical to model complex interactions in order
to elucidate the joint genetic effects that may cause
complex diseases. They have demonstrated the presence
of gene-gene interactions in complex diseases such as
breast cancer5 and coronary heart disease.6 The problem
of detecting gene-gene interactions in genome-wide case-
control studies has attracted extensive research interest.
The difficulty in this problem is the heavy computational
burden. For example, in order to detect pairwise interac-
tions from 500,000 SNPs genotyped in thousands of
samples, we need 1.25 3 1011 statistical tests in total.
A recent review4 presented a detailed analysis on many
popular methods that detect epistasis on the basis of the
statistical definition, including MDR,5 PLINK,7 Tuning
ReliefF,8 Random Jungle,9 BEAM,10 and three proposed
search strategies.11
Among them, BEAM and MDR were reported to have
difficulties in handling 500,000 SNPs genotyped in thou-
sands of samples.4 Both methods need a prescreening
process to reduce the number of SNPs in order to analyze
the large data sets. Marchini et al.11 demonstrated that
it is feasible to test association allowing for interactions
in a genome-wide scale. Random Jungle can handle
genome-wide data efficiently. However, both Marchini’s
method and Random Jungle aim at testing associations
allowing for interactions, which is easier than testing inter-
actions (we have detailed explanations of a test of associa-
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Table 1. The Genotype Counts in Cases and Controls
Y ¼ 1 Xq ¼ 1 Xq ¼ 2 Xq ¼ 3 Y ¼ 2 Xq ¼ 1 Xq ¼ 2 Xq ¼ 3
Xp ¼ 1 n111 n121 n131 Xp ¼ 1 n112 n122 n132
Xp ¼ 2 n211 n221 n231 Xp ¼ 2 n212 n222 n232
Xp ¼ 3 n311 n321 n331 Xp ¼ 3 n312 n322 n332
Cases are denoted with Y ¼ 1 and controls with Y ¼ 2.the Discussion). PLINK was recommended as the most
computationally feasible method that is able to detect
gene-gene interactions in genome-wide data.4 PLINK
finished a pairwise interaction examination of 89,294
SNPs selected from the WTCCC Crohn disease data set in
14 days. To accelerate the analysis process in genome-
wide association studies (GWAS), the parallel computation
was recommended.4,12
Here, we propose a fast method, named ‘‘BOolean Oper-
ation-based Screening and Testing’’ (BOOST), for the anal-
ysis of all pairwise interactions in genome-wide SNP data.
In our method, we design a Boolean representation of
genotype data, which promotes not only space efficiency
but also CPU efficiency because it involves only Boolean
values and allows for the use of fast logic (bitwise) opera-
tions to obtain contingency tables. On the basis of this
data representation, we propose a two-stage (screening
and testing) search method. In the screening stage, we
use a noniterative method to approximate the likelihood
ratio statistic in evaluating all pairs of SNPs and select those
passing a specified threshold. Most nonsignificant interac-
tions will be filtered out, and the survival of significant
interactions is guaranteed. In the testing stage, we employ
the classical likelihood ratio test to measure the interaction
effects of selected SNP pairs. Experiments on WTCCC data
sets show that our method is faster than current methods.
This efficiency helps to identify interesting interaction
patterns from the type 1 diabetes data set and the rheuma-
toid arthritis data set.Material and Methods
Notation
Suppose we have L SNPs and n samples. We use Xl to denote the
l-th SNP, l ¼ 1;/;L, and Y to denote the class label (1 for case
and 2 for control). SNPs are biallelic genetic markers in genome-
wide case-control studies. In general, we use capital letters (e.g.,
A, B, .) to denote major alleles and use lowercase letters (e.g.,
a, b,.) to denoteminor alleles. For each SNP, there are three geno-
types: the homozygous reference genotype (AA), the heterozygous
genotype (Aa), and the homozygous variant genotype (aa). The
popular way of coding the genotype data is to use {1, 2, 3} to repre-
sent {AA, Aa, aa}, respectively.
Definition of Interaction via Logistic Regression
Models
Interactions are often defined via logistic regressionmodels.13 The
logistic regression model with only main effects, i.e., the main
effect model, has the following form:
log
P

Y ¼ 1 jXp ¼ i;Xq ¼ j

P

Y ¼ 2 jXp ¼ i;Xq ¼ j
 ¼ b0 þ bXpi þ bXqj (Equation 1)
The logistic regression model with both main effect terms and
interaction terms, i.e., the full model, has the following form:
log
P

Y ¼ 1 jXp ¼ i;Xq ¼ j

P

Y ¼ 2 jXp ¼ i;Xq ¼ j
 ¼ b0 þ bXpi þ bXqj þ bXpXqij (Equation 2)326 The American Journal of Human Genetics 87, 325–340, SeptembPlease note that the superscript Xp of b
Xp
i in both equations is
merely a label and does not represent the exponent. The term
b
Xp
i represents the coefficient of Xp at category i. This representa-
tion extends to b
Xq
j and b
XpXq
ij as well. There are five coefficients
in Equation 1 and nine coefficients in Equation 2. This is because
one category of both Xp and Xq is used as the reference. This nota-
tion is adopted by Agresti14 to make the representations of logistic
regression models and log-linear models (introduced later) more
compact.
Let LM and LF be the log-likelihoods of the main effect model
and the full model, respectively. According to the likelihood
ratio test, interaction effects are defined as the difference of the
log-likelihoods of these two models evaluated at their maximum
likelihood estimations (MLEs), i.e., bLF  bLM . Hence, interaction
effects can be interpreted as the departure from linear models
naturally.4
However, it is computationally unaffordable to directly use this
measure to evaluate all pairs of SNPs in a genome-wide case-
control study because there are hundreds of billions of pairs to
be tested. Therefore, faster test procedures without the loss of
statistical powers are needed in GWAS. Noticing the equivalence
between a logistic regression model and its corresponding log-
linear model,14 here we propose to test two-locus interactions on
the basis of log-linear models. The advantage of so doing is that
the test statistic can be quickly approximated without iteration.
Log-Linear Models for Contingency Tables
To test the interaction effect between two SNPs (Xp,Xq) and disease
status Y by using log-linear models, a contingency table of
these three variables will be used (see Table 1). The size of the
contingency table is I 3 J 3 K, where I ¼ 3, J ¼ 3 and K ¼ 2. In
Table 1, nijk is used to denote the observed count in the cell (i, j, k).
It is considered as a realization of a random variable Nijk
assumed as Poisson distributed. We use pijk to denote the proba-
bility that an observation falls in the cell (i, j, k). A natural
constraint of pijk is X
i;j;k
pijk ¼ 1 (Equation 3)
We use the dot convention to indicate summation over a
subscript; e.g., pi:: ¼
P
j;k pijk is the marginal probability of Xp ¼ i,
and ni:: ¼
P
j;k nijk is the number of observations with Xp ¼ i. The
notation extends to two dimensions as well. For example,
pij: ¼
P
k pijk is the marginal probability of Xp ¼ i and Xq ¼ j, and
nij: ¼
P
k nijk is the corresponding count. Clearly, we have
n ¼Pi;j;k nijk.
Log-linear models treat Nijk as independent Poisson random
variables with their means as follows:
mijk ¼ npijk (Equation 4)er 10, 2010
Table 2. Equivalence between Log-Linear Models and Logistic Models for a Three-Way Table with Binary Response Variable Y
Log-Linear Model Logistic Model MLE of mijk
Block independence model (MB): logmijk ¼ lþ lXpi þ l
Xq
j þ lYk þ l
XpXq
j b0
nij :n::k
n
Partial independence model (MP): logmijk ¼ lþ lXpi þ l
Xq
j þ lYk þ l
XpXq
ij þ l
XpY
ik b0 þ b
Xp
i
ni :k
n :jk
n::k
Homogeneous association model (MH): logmijk ¼ lþ lXpi þ l
Xq
j þ lYk þ l
XpXq
ij þ l
XpY
ik þ l
XqY
jk b0 þ b
Xp
i þ b
Xq
j iterative estimation
Saturated model (MS): logmijk ¼ lþ lXpi þ l
Xq
j þ lYk þ l
XpXq
ij þ l
XpY
ik þ l
XqY
jk þ l
XpXqY
ijk b0 þ b
Xp
i þ b
Xq
j þ b
XpXq
ij nijk
The modelsMB andMP are used in the discussion of the difference between the test of interactions and the test of associations. The details of these two models are
provided in the Appendix.The likelihood function is
f ðmÞ ¼
Y
i;j;k
emijkm
nijk
ijk
nijk!
(Equation 5)
Correspondingly, the log-likelihood function is
LðmÞ ¼
X
i;j;k

nijklog

mijk
 mijk  lognijk! (Equation 6)
In the space of log-linear models, the homogeneous association
model is the equivalent form of the logistic regression model with
onlymain effects (defined in Equation 1), and the saturatedmodel
matches the full logistic regression model (defined in Equation 2).
Table 2 summarizes the equivalence between log-linear models
and logistic models for a three-way contingency table. The details
are provided in the Appendix. In the following text, we explain
how these two models are used to test interactions.
Measuring Interaction via Log-Linear Models
On the basis of the equivalence between the log-linear model and
its corresponding logistic regression model, we construct our test
statistic using the homogeneous association model MH and the
saturated model MS. Let LH and LS be the log-likelihood of MH
and MS, respectively. According to Equation 6 and the MLE of
mijk inMS (see Table 2 and the Appendix), the maximum log-likeli-
hood of MS is
bLS ¼X
i;j;k

nijklognijk  nijk  log

nijk!

(Equation 7)
The log-likelihood of MH is maximized at its MLE bmHijk:
bmHijk ¼ argmax
mijk
LH ¼ argmax
mijk
X
i;j;k

nijklogmijk  mijk  log

nijk!

(Equation 8)
In other words,
bLH ¼ LHbmHijk ¼ max
mijk
LH

mijk

(Equation 9)
Notice that bmHijk always exists and is unique because of the
concavity of LH. To measure interaction effects based on the likeli-
hood ratio test, we have
bLS  bLH ¼X
i;j;k
"
nijklog
nijkbmHijk  nijk þ bmHijk
#
(Equation 10)
Because Equation 4 implies thatX
i;j;k
bmHijk ¼ n (Equation 11)The AmericanEquation 10 can be further reduced as
bLS  bLH ¼P
i;j;k
"
nijklog
nijkbmHijk
#
¼ nP
i;j;k

nijk
n
log
nijk=nbmHijk=n
	
¼ nP
i;j;k
bpijklogbpijkbpijk
	
¼ n$DKL
bpijkkbpijk
(Equation 12)
where DKLðbpijkkbpijkÞ is the Kullback-Leibler divergence of bpijk
and bpijk.
The new measure DKLðbpijkkbpijkÞ provides us another interpreta-
tion of interactions. Equation 12 shows that the difference of
the two log-likelihoods is proportional to the Kullback-Leibler
divergence of the joint distribution bpijk obtained under the
saturated model MS, and the distribution bpijk obtained under
the homogeneous association model MH. The distribution bpijk is
constructed via lower-order distributions (see the Appendix).
From the perspective of log-linear models, interaction effects
can be understood as the information contained in the joint dis-
tribution but not in its lower-order factorization, which is known
as ‘‘synergy’’ in physics.15 If no interaction effects exist, the
joint distribution can be well characterized by its lower-order
factorization.
Boolean Operation-Based Screening and Testing
Boolean Representation of Genotype Data
The data set containing L SNPs and n samples is usually stored in
an L3nmatrix. Each cell in this matrix takes a value from {1, 2, 3},
the elements of which represent the homozygous reference geno-
type, the heterozygous genotype, and the homozygous variant
genotype, respectively. In our method, we introduce a Boolean
representation of genotype data (the details are provided in the
Appendix). This Boolean representation enables us to collect
contingency tables in a fast manner.
Screening and Testing
Directly using bLS  bLH to test interactions in GWAS still has some
difficulties, because no closed-form solution exists for the homog-
enous association model MH. Iterative methods are needed in
model fitting to compute bLH . This will be computationally inten-
sive when we face hundreds of billions of SNP pairs.
To solve this issue, we propose to approximate the homogenous
association model MH with the Kirkwood superposition approxi-
mation (KSA):15
bp Kijk ¼ 1h pij:pi:kp:jkpi::p:j:p::k (Equation 13)Journal of Human Genetics 87, 325–340, September 10, 2010 327
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Figure 1. KSA Performance in Simulation
(A) The LD (measured by r2) pattern of simulated data from theHapmap data. To show the block structure clearly, we show only the LD of
the first 500 SNPs here. The LD block structure of all 2000 SNPs is very similar.
(B) Comparison of the values 2ðbLS  bLKSAÞ and 2ðbLS  bLHÞ based on KSA and log-linear models. KSA overestimation
2ðbLS  bLHÞ%2ðbLS  bLKSAÞ is illustrated here. For the region [25, þ N), 2ðbLS  bLKSAÞ is almost identical to 2ðbLS  bLHÞ.
where h ¼Pi;j;k pij:pi:kp:jkpi::p:j:p::k is a normalization term. The benefit of
using KSA is two-fold:
First, bLS  bLKSA is an upper bound of bLS  bLH ; i.e.,
bLS  bLH%bLS  bLKSA (Equation 14)
where bLKSA is the log-likelihood evaluated at the MLE bmKijk of the
KSA model (see the proof in the Appendix).
Noticing that the calculation of bpKijk is straightforward and no
iteration is involved, the approximated measure 2ðbLS  bLKSAÞ ¼
2n,DKLðbpijkkbpKijkÞ can be obtained easily on the basis of the contin-
gency table collected by the Boolean operation. Therefore, the
KSA model can be applied to evaluate hundreds of billions of
SNP pairs. Because we are interested only in interactions with large
2ðbLS  bLHÞ values, we can first filter out those SNP pairs with
2ðbLS  bLKSAÞ%t by using a threshold t, and we can then conduct
statistical tests on the remaining SNP pairs.
Second, the bound in Equation 14 is tight. When the
joint distribution is pKijk (Equation 13), the equality holds; i.e.,bLS  bLKSA ¼ bLS  bLH . This bound is very close to the statisticbLS  bLH of the likelihood ratio test. To illustrate the tightness of
the bound, we use the simulation method proposed by Li et al.16
to generate a data set containing 2000 SNPs and 1000 samples
based onHapMapdata. Figure 1A shows the linkage disequilibrium
(LD) pattern of the simulated data, which is very similar to the real
data. Using this data, we calculate 2ðbLS  bLKSAÞ ¼ 2n,DKLðbpijkkbpKijkÞ
based on the KSA and 2ðbLS  bLHÞ ¼ 2n,DKLðbpijkkbpijkÞ based on log-
linear models for all pairs of 2000 SNPs. Figure 1B shows the
comparison of these two models. It can be seen that 2ðbLS  bLKSAÞ
consistently overestimates 2ðbLS  bLHÞ. For the region [25, þ N],
2ðbLS  bLKSAÞ is almost identical to 2ðbLS  bLHÞ.
In summary, most nonsignificant interactions can be filtered
out because of the tightness of the bound (Equation 14) and the
survival of significant interactions is guaranteed. On the basis of
this upper bound, we propose our method, BOOST:
Stage 1: Screening. We evaluate all pairwise interactions by using
the KSA in the screening stage. For each pair, the calculation of328 The American Journal of Human Genetics 87, 325–340, Septemb2ðbLS  bLKSAÞ is based on the contingency table collected by using
Boolean operations. Because 2ðbLS  bLHÞ%2ðbLS  bLKSAÞ, an interac-
tion obtained by the KSA without passing a specified threshold t,
i.e., 2ðbLS  bLKSAÞ%t, would not be considered in stage 2. The
threshold t corresponds to the significant threshold (with the
Bonferroni correction) specified by users. Because the Bonferroni
correction tends to be conservative, a smaller threshold can be
used to put more SNP pairs into the testing stage. We set t ¼ 30
in our experiments to test the computational capacity of our
method. The threshold t ¼ 30 corresponds to the unadjusted
p ¼ 4.89 3 106, which is a very weak significance level for a
genome-wide study.
Stage 2: Testing. For each pair with 2ðbLS  bLKSAÞ > t, we test the
interaction effect using the likelihood ratio statistic 2ðbLS  bLHÞ.
We fit the log-linear models MH and MS and calculate this test
statistic using Equation 12. After that, we conduct the c2 test
with four degrees of freedom (df ¼ 4) to determine whether the
interaction effect is significant. The p value is adjusted by the Bon-
ferroni correction, with the number of tests LðL  1Þ=2, where L is
the total number of SNPs before screening.
To approximate MH, we may also choose some other log-linear
models, such as the block independence model MB or the partial
independence model MP (see Table 2). However, such approxima-
tions will lead to very loose bounds, leaving millions of SNP pairs
to be examined in the testing stage. Using the KSA, we have empir-
ically observed that 300,000~600,000 SNP pairs are examined in
the testing stage when the WTCCC data are analyzed. When the
partial independence model is used, the number of SNP pairs is
up to 108~109.Results
Experiments on Simulation Data
The performance of our approach is evaluated through
comparative studies with existing works. Our goal is toer 10, 2010
discover epistatic interactions from genome-wide data.
Among many methods recently proposed, we mainly
compare BOOST with PLINK7 with respect to the power
of gene-gene interaction identification. The reasons for
choosing PLINK for comparison are as follows:
d A recent review4 tested many available methods and
recommended PLINK as a powerful tool for testing
interactions on a genome-wide scale.
d Both PLINK and BOOST use an exhaustive search
strategy. The comparison of their performance is fair.
We conduct the following simulation studies to compare
BOOSTwith PLINK (tested with the ‘‘-fast-epistasis’’ option
and without the ‘‘-case-only’’ option):
d Case 1: Disease loci with main effects.
d Case 2: Disease loci without main effects.
d Case 3: Genetic heterogeneity.
d Case 4: Null simulation for testing type I errors.
Case 1: Disease Loci with Main Effects
We consider four epistasis models whose odds tables are
given in Table S7, available online. Model 1 is a multiplica-
tive model.11 Model 2 is an epistasis model17 that has been
used to describe handedness18 and the color of swine.19
Model 3 is a classical epistasis model.20,21 Model 4 is the
well known XOR (exclusive OR) model.
Let p(DjGi) denote the probability of an individual being
affected given its genotype combination Gi (i.e., the pene-
trance of Gi), and let pðDjGiÞ denote the probability of an
individual not being affected given its genotype Gi. On
the basis of the definition of the odds of a disease,
ODDGi ¼
pðD jGiÞ
pðD jGiÞ
¼ pðD jGiÞ
1 pðD jGiÞ (Equation 15)
the penetrance p(DjGi) of the genotypeGi can be calculated
by using
pðD jGiÞ ¼ ODDGi
1þ ODDGi
(Equation 16)
The disease prevalence p(D) and genetic heritability h2
are given as
pðDÞ ¼
X
i
pðD jGiÞpðGiÞ (Equation 17)
h2 ¼
P
iðpðD jGiÞ  pðDÞÞ2pðGiÞ
pðDÞð1 pðDÞÞ (Equation 18)
In our simulation, the prevalence p(D) and the herita-
bility h2 are controlled by the parameters a and q (see
Table S6). We first specify the disease prevalence p(D) and
the genetic heritability h2, and we then numerically solve
the parameters (a and q) on the basis of the above equa-
tions. For example, we set p(D) ¼ 0.1 and h2 ¼ 0.03 inThe Americanmodel 1. Then we obtain a ¼ 0.09989 and q ¼ 3.4481 for
minor allele frequency (MAF) ¼ 0.1.
In the simulation, we set h2 ¼ 0.03 for model 1 and h2 ¼
0.02 for models 2, 3, and 4. We generate genotype data on
the basis of the Hardy-Weinberg principle. We set the
MAFs of disease-associated SNPs to be 0.1, 0.2, and 0.4.
We generate the MAFs of unassociated SNPs uniformly
from [0.05, 0.5]. We simulate 100 data sets under each
setting for each disease model. Each data set contains
1000 SNPs. To take sample size into consideration, we
simulate both 800 samples and 1600 samples with the
balanced design.
Figure 2 presents the comparison results with the signif-
icance thresholds selected as 0.1, 0.2, and 0.3 after the
Bonferroni correction. For model 1 with MAF ¼ 0.2, 0.4
andmodel 2 withMAF¼ 0.1, the statistical power of PLINK
is higher. This is because these model settings are well
captured by the allele interaction test. For all other settings,
BOOST outperforms PLINK.
Case 2: Disease Loci without Main Effects
Disease models displaying no main effects22 have been
carefully discussed, and a wide spectrum of these models23
has been provided. In this experiment, we use all of these
70 pure epistatic models without main effect to compare
performance. For convenience, these models are listed in
Tables S8–S14. The heritability h2 controls the phenotypic
variation of these 70 models, which ranges from 0.01 to
0.4. The MAF ranges from 0.2 to 0.4. For each model, the
statistical power is evaluated under different sample sizes,
including n ¼ 400, n ¼ 800, and n ¼ 1, 600 (half controls
and half cases). For each setting, 100 data sets are gener-
ated. Each data set contains 1000 SNPs.
Please check Figures S4–S7 to see the comparison results
for the 70 models. For some models, such as model epi1–5,
BOOST and PLINK perform equally well. For most of
these models, BOOST is superior to PLINK because the
interaction patterns cannot be well characterized by allele
interactions.
Case 3: Genetic Heterogeneity
Genetic heterogeneity refers to the phenomenon that
a disease is affected by different subsets of genes. It plays
a substantial role in complex human diseases.24 Here, we
set up a simulation study to show the performance of
BOOST and PLINK when genetic heterogeneity is present.
We choose some epistatic models used in case 2 to generate
the data. The heritability h2 of these models ranges from
0.01 to 0.4. Different sample sizes, including n ¼ 400,
n ¼ 800 and n ¼ 1600, are simulated for each model.
The details of simulation are provided in the Appendix.
The performance of both BOOST and PLINK is given
in Figure S8. Genetic heterogeneity affects the perfor-
mance of both BOOST and PLINK. In general, their
performance degrades as heritability h2 decreases. The
sample size plays an important role when genetic hetero-
geneity is present. When the sample size increases from
400 to 1600, the power of both BOOST and PLINK
increases a lot.Journal of Human Genetics 87, 325–340, September 10, 2010 329
Figure 2. The Performance Comparison between BOOST and PLINK on Four Disease Models
Under each parameter setting, 100 data sets are generated. Both 800 samples and 1600 samples with balanced design are simulated. The
power is calculated as the proportion of the 100 data sets in which the interactions of the disease-associated SNPs are detected. The
absence of bars indicates no power.Case 4: Null Simulation for Testing Type I Errors
To compare BOOST and PLINK in terms of type I errors, we
conduct null simulation in two scenarios:
d Scenario 1: Without LD. We generate 1000 null data
sets. Each data set contains 1000 SNPs and 1000
samples. All of the SNPs are generated independently,
with MAFs uniformly distributed in [0.05, 0.5]. The
result is shown in Figure 3A. It can be seen that the
type I error of BOOST agrees with the nominal error
rate and the type I error of PLINK is a little bit less
than the nominal error rate.
d Scenario 2: With LD. The simulation program
‘‘genomeSIMLA’’25 is used to simulate the SNP data
on the basis of themarker information on the Affyme-
trix 500K chip from human chromosome 1. LD exists
among SNPs. We generate 100 null data sets, each of
which contains 38,836 SNPs and 1000 samples. The
result is shown in Figure 3B. Because of the LDpattern,
the error rates of both methods are lower than the
nominal error rate, confirming that the Bonferroni
correction is conservative. Surprisingly, unlike the
situation in scenario 1, the error rate of BOOST is less
than that of PLINK. The reason is that some cells of
a contingency table may be empty when LD exists.
This leads to the true degree of freedom dftrue % 4.330 The American Journal of Human Genetics 87, 325–340, SeptembBecause we calculate p values by using the c2 distribu-
tion with df ¼ 4, BOOST has a lower type I error
rate than PLINK. This simulation study also implies
that it is possible to increase the power of BOOST by
using a more accurate degree of freedom in statistical
tests.
Experiments on WTCCC data
We have applied BOOST to analyze data (14,000 cases in
total and 3000 shared controls) from theWTCCC on seven
common human diseases: bipolar disorder (BD), coronary
artery disease (CAD), Crohn disease (CD), hypertension
(HT), rheumatoid arthritis (RA), type 1 diabetes (T1D),
and type 2 diabetes (T2D). The procedure of quality control
is presented in the Appendix. The results under different
constraints are reported in Table 3. For T1D, we discovered
many gene-gene interactions in the MHC region (see
detailed descriptions in the following section). For the
other six diseases, however, we did not find nontrivial
interactions (except one SNP pair in CD).
T1D and RA
The MHC region in chromosome 6 has long been investi-
gated as the most variable region in the human genome
with respect to infection, inflammation, autoimmunity,
and transplant medicine.26 The recent study conducted
by the WTCCC27 has shown that both T1D and RA areer 10, 2010
A B Figure 3. Comparison of the Type I Error
Rates in Null Simulation
(a) Null simulation with no LD.
(b) Null simulation with LD.strongly associated with the MHC region via single-locus
association mapping. The top-left panel of Figure 4 shows
that the single-locus associationmap does not reveal much
difference between T1D and RA. In our study, BOOST
reports 4499 interactions in the T1D data set (see Table 3),
in which 4489 interactions (99.8%) are in theMHC region.
Clayton’s analysis28 on the T1D data set found that with
the exception of strong interactions within the MHC
region, interactions are small and have a modest effect
on prediction. Our results have verified Clayton’s finding
from another perspective. As a comparison, BOOST reports
350 interactions in the RA data set, in which 280 interac-
tions (80.0%) are in the MHC region. Our genome-wide
interaction map provides evidence that the MHC region
is associated with these two diseases in different ways.
The bottom panel of Figure 4 gives detailed interaction
maps in the MHC region for T1D and RA data. We further
calculate composite LD using themethod by Zaykin et al.29
The LD map of MHC region is provided in the top-right
panel of Figure 4. These interaction maps, different
from the LD map, reveal a distinct pattern difference
between T1D and RA. Specifically, there are three subre-
gions in the MHC region: namely, the MHC class I region
(29.8Mb–31.6Mb), the MHC class III region (31.6Mb–Table 3. The Number of Interactions Identified from the WTCCC
Data Sets of Seven Diseases under Different Constraints
BD CAD CD HT RA T1D T2D
C1 10 16 8 7 350 4499 18
C1 & C2 0 0 1 0 0 789 0
C1 & C2 & C3 0 0 1 0 0 91 0
Abbreviations are as follows: BD, bipolar disorder; CAD, coronary artery
disease; CD, Crohn disease; HT, hypertension; RA, rheumatoid arthritis; T1D,
type 1 diabetes; T2D, type 2 diabetes. C1 is the significance threshold
constraint: the significance threshold is 0.05 for the Bonferroni-corrected inter-
action p value. C2 is the distance constraint: the physical distance between two
interacting SNPs is at least 1Mb. This constraint is used to avoid interactions
that might be attributed to the LD effects.4 C3 is the main effect constraint:
The single-locus p value should not be less than 106. This constraint is used
to see whether there exist strong interactions without significant main effects,
because those SNPs with pR 106 are usually filtered out in the typical single-
locus scan.
The American Journal of Human Genet32.3Mb), and the MHC class II region
(32.3Mb–33.4Mb). A closer inspec-
tion of the T1D interaction map indi-
cates that strong interaction effects
widely exist between genes within
and across three classes, whereas
most significant interactions in RA
involve only loci closely placed inthe MHC class II region. The contrast of the interaction
patterns between T1D and RA may explain their different
etiologies, which are not revealed by single-locus associa-
tion mapping.
Interactions without Significant Main Effects Detected in T1D
The mathematical property of interactions without signif-
icant main effects has been discussed in detail.22 The
existence of these interactions has been shown from the
experiment results based on relatively small numbers of
SNPs.5,6 Here, we provide the result identified in the
genome-wide scale. The MHC region is a highly polymor-
phic region with a high gene density. Although previous
reports27,30 using the single-locus scan have identified
strong associations between MHC genes (such as HLA-
DQB1 and HLA-DRB1) and T1D, it is still unclear which
and how many loci within the MHC region determine
T1D susceptibility. Interactions without significant main
effects can provide additional information to help pin-
point disease-associated loci, because SNPs involved in
those interactions are usually filtered out in the single-
locus scan.
Among the selected 789 interacting pairs in T1D, 91
pairs have nonsignificant loci under the single-locus
scan (all of them are listed in Table S6). A careful inspec-
tion of these 91 interactions has identified two interest-
ing interaction patterns between the MHC class I and
class II. One interaction pattern involves the 31350k–
31390k region (see Figure 5) and the 32810k–32860k
region (see Figure 6) in chromosome 6 (please check
more results in the Appendix). The interactions between
two regions in these two figures are listed in Table 4.
All SNPs in these interactions display weak main effects,
whereas their joint effects are statistically significant.
The potential pathways involving HLA_B, HLA_DQA2,
and PSMB8 are shown in Figure 7. HLA_B, HLA_DQA2,
and PSMB8 potentially interact in the antigen-process-
ing and -presentation pathway.31–34 HLA_B and HLA_
DQA2 potentially interact in the type 1 diabetes mellitus
pathway.30,35,36 As Nejentsev et al.30 argued that both
the MHC class I and II genes should be considered to
better understand type 1 diabetes susceptibility, our
results provide further evidence that the interactionics 87, 325–340, September 10, 2010 331
Figure 4. Comparison between the Single-Locus Association Mapping and the Interaction Mapping for T1D and RA
Top-left panel: Single-locus association mapping of T1D and RA. These two share a very similar hit region in chromosome 6.
Top-right panel: The LD map of the MHC region in control samples.
Bottom panel: Genome-wide interaction mapping of T1D and RA. 99.8% of T1D interactions and 80.0% of RA interactions are in the
MHC region. Strong interaction effects widely exist between genes in and across the MHC class I, II, and III in T1D, whereas most signif-
icant interactions of RA involve only loci closely placed in the MHC class II region (The p values are truncated at p ¼ 1.0 3 1016).effects between these two classes may contribute to the
etiology of type 1 diabetes.
Discussion
Relationship between Our Method and Other
Two-Stage Methods
The analysis of GWAS data is a challenging computational
problem. To speed up this process, many methods4,5,11
have been coupled with some prescreening algorithms to
reduce the number of SNPs. Most of the currently available
screening algorithms are based on single-locus tests and
can be finished very quickly. However, for some SNPs
with weak main effects but significant interactions, these
screening algorithms will filter them out. Our screening
method does not have this issue. It uses a fast approxima-
tion to evaluate all SNP pairs with the guarantee that
significant interactions will not be filtered out no matter
whether individual SNPs display main effects or not.332 The American Journal of Human Genetics 87, 325–340, SeptembRelationship between Our Method and PLINK
Both BOOST and PLINK use the exhaustive search to find
epistatic interactions in GWAS. The key difference between
BOOST and PLINK is the way that they test interaction
effects:
d PLINK tests interactions based on alleles.7 Three geno-
type categories are collapsed into two allele cate-
gories. Correspondingly, 3 3 3 contingency tables
are collapsed into 2 3 2 tables. The difference of the
odds ratios from the two 2 3 2 tables (one for cases
and the other for controls) is used to construct a c2
test with df ¼ 1.
d BOOST tests interactions based on genotypes, using
the c2 test with df ¼ 4.
In general, if the underlying interaction could be well
characterized by an allele interaction, then the statistical
power of PLINK would be higher than that of BOOST.er 10, 2010
Figure 5. The 31350k–31390k Region of Chromosome 6
HLA-B in the MHC class I is located in this region. The recombination rate and LD plot from HapMap show that a block structure exists
from 31360k to 31380k. This region is mapped through the SNPs rs2524057, rs2853934, rs2524115, rs396038, rs3873385, rs2524095,
and rs2524089. The SNPs rs2524095 and rs2524089 are involved in the interactions with the 32930k–32960k region shown in Figure S2.However, the type of underlying interaction is generally
unknown and may vary widely.22 BOOST is more flexible
because it covers a larger model space than PLINK. BOOST
can bemodified to test the allelicmodel by collapsing 33 3
contingency tables to 2 3 2 contingency tables (in the
same way that PLINK does). The two-stage strategy in
BOOST can then be applied to these 2 3 2 contingency
tables. The statistical power of the modified BOOST will
be roughly the same as PLINK because they both are based
on the same allelic model. The ignorable difference is due
to the difference between the Wald test and the likelihood
ratio test. In the released software of BOOST, the allelic test
has also been implemented. Regarding the running
time, the BOOST allelic test is similar to the BOOST geno-
type test.
Relationship between Our Method and INTERSNP
Recently, INTERSNP37 has implemented the interaction
test in GWAS using log-linear models. Regarding the
interaction test, both INTERSNP and our work are devel-
oped on the basis of the standardized definition using
logistic regression models.13 INTERSNP has directly usedThe Americanan iterative method to fit the log-linear model MH. It is
still very time consuming to test interactions in GWAS.
Therefore, INTERSNP suggests the use of some prior knowl-
edge to reduce the number of SNPs, including the single-
locus test, genetics criteria, and pathway information.
Genetics criteria and pathway information provide biolog-
ical constraints that are very useful. But using the single-
locus test in the filtering, which has been discussed in
the earlier section, will filter out those SNPs with weak
main effects but significant interactions. Moreover, how
to choose the threshold in filtering is also critical. On the
contrary, we propose to use the noniterative approxima-
tion to directly examine all SNPs pairs. We show the
computational performance of BOOST and INTERSNP in
the following section.
Computation Time
From a practical point of view, a key issue of detecting
gene-gene interactions in genome-wide case-control
studies is the computational efficiency. Cordell4 reported
that PLINK took about 14 days to test pairwise interactions
of the selected 89,294 SNPs on a single node of a computerJournal of Human Genetics 87, 325–340, September 10, 2010 333
Figure 6. The 32810k–32860k Region of Chromosome 6
HLA-DQA2 andHLA-DQB2 in theMHC class II reside in this region. The recombination rate and LD plot fromHapMap show that a block
structure exists from 32820k to 32847k. This region is mapped through the genotyped SNPs rs9276448, rs5014418, and rs6919798. The
ungenotyped SNPs rs9276438 and rs7774954 reside in HLA-DQA2 and HLA-DQB2, respectively. They are in strong LD with those
genotyped SNPs.cluster. Random Jungle can analyze the large data sets
quickly. However, Random Jungle aims at detecting associ-
ation allowing for interactions rather than detecting inter-
actions (see detailed explanations in the next subsection).
Besides, Random Jungle has difficulty in finding interact-
ing SNP pairs displaying weak main effects because trees
built in Random Jungle rely on the main effects of SNPs.
BEAM took about 8 days to handle 47,727 SNPs using
5 3 107 Markov chain Monte Carlo iterations. Currently,
BEAM has difficulties in handling 500,000 to 1,000,000
SNPs genotyped in 5000 or more samples. Cordell4 recom-
mended PLINK as a powerful method of testing interac-
tions in GWAS.
We tested the running time of PLINK on our desktop
computer. In addition, we also tested INTERSNP on the
same data sets because INTERSNP also uses log-linear
models to test interactions. The results are shown in
Table 5. BOOST is roughly 63 times faster than PLINK
and 95 times faster than INTERSNP. It can finish the anal-
ysis of all pairs of roughly 360,000 SNPs within 60 hr
(around 2.5 days) on a standard desktop (3.0 GHz CPU334 The American Journal of Human Genetics 87, 325–340, Septembwith 4G memory running the Windows XP Professional
x64 edition system). Parallel computing12 can be used to
further improve the computation time for BOOST, PLINK,
and INTERSNP. The WTCCC phase 2 study will analyze
over 60,000 samples of various diseases using either the
Affymetrix v6.0 chip or the Illumina 660K chip. The
shared control samples will increase from 3000 to 6000.
Such an increase in the number of SNPs and the sample
size is more demanding on the computation efficiency.
We anticipate that BOOST is still applicable for analyzing
the new data sets.
Test of interactions versus Test of Associations
To test association between a specific SNP Xp and the
phenotype Y, a typical method is to test the difference
between the deviance of the null model (Equation 19)
and the deviance of the alternative model (Equation 20)
with df ¼ 2:
log
PðY ¼ 1Þ
PðY ¼ 2Þ ¼ b0 (Equation 19)er 10, 2010
Table 4. The Interaction SNP Pairs in the Two Regions Shown in
Figure 5 and Figure 6
SNP 1 SNP 2 Interaction
SNP
Single-Locus
p Value SNP
Single-Locus
p Value BOOST p Value
rs2524057 4.807 3 101 rs9276448 8.878 3 103 5.362 3 1014
rs2524057 4.807 3 101 rs5014418 1.116 3 102 2.738 3 1013
rs2853934 8.336 3 102 rs9276448 8.878 3 103 2.507 3 1013
rs2524115 1.215 3 101 rs9276448 8.878 3 103 6.456 3 1013
rs3873385 3.368 3 101 rs9276448 8.878 3 103 3.186 3 1014
rs3873385 3.368 3 101 rs5014418 1.116 3 102 3.841 3 1014
rs3873385 3.368 3 101 rs6919798 6.077 3 102 4.257 3 1013
rs396038 9.939 3 102 rs9276448 8.878 3 103 5.894 3 1013
The SNPs in the SNP 1 column reside in HLA-B, and the SNPs in the SNP 2
column are located at the block across HLA-DQA2 and HLA-DQB2. They show
HLA-B
HLA-DQA2 PSMB8
T1DM
Antigen
Figure 7. Potential Pathways Involving HLA_B, HLA_DQA2, and
PSMB8
T1DM represents the type 1 diabetes mellitus pathway. Antigen
represents the antigen processing and presentation pathway.
Table 5. Time Comparison of BOOST, PLINK, and INTERSNP
Data Size BOOST PLINK INTERSNP
n ¼ 5000, L ¼ 1000 < 2s 106s 160s
n ¼ 5000, L ¼ 5000 42s 2703s 4277s
n ¼ 5000, L ¼ 10,000 170s 10,915s 15,805s
PLINK is tested with the ‘‘–fast-epistasis’’ option and without the ‘‘–case-only’’
option. All timings are carried out on a 3.0 GHz CPU with 4G memory running
the Windows XP Professional system.log
P

Y ¼ 1 jXp ¼ i

P

Y ¼ 2 jXp ¼ i
 ¼ b0 þ bXpi (Equation 20)
This is known as a ‘‘test of single-SNP association.’’
In the above test, SNP Xp is allowed to interact with
other SNPs. As a matter of fact, if the disease is influenced
by SNP Xp itself and its interaction effect with another
SNP Xq, the statistical power of detecting SNP Xp will
be increased when allowing for interactions. This is
known as a ‘‘test of two-locus associations allowing for
interactions’’4. Typically, this is accomplished by testing
the difference between the log-likelihood of the null
model (Equation 19) and that of the alternative model
(Equation 21) with df ¼ 8:
log
P

Y ¼ 1 jXp ¼ i;Xq ¼ j

P

Y ¼ 2 jXp ¼ i;Xq ¼ j
 ¼ b0 þ bXpi þ bXqj þ bXpXqi;j
(Equation 21)
Marchini et al.11 highlighted the importance of testing
associations allowing for interactions in a genome-wide
scale and successfully demonstrated its feasibility. They
reported that performing all pairwise tests of associations
allowing for interactions with df ¼ 8 at 300,000 loci with
1000 cases and 1000 controls can be finished in 33 hr on
a 10-node cluster. According to the equivalence between
log-linear models and logistic models, it is clear that the
feasibility of this exhaustive search method relies on the
closed-form solution of the block independence model
MB and the closed-form solution of the saturated model
MS (see the Appendix for the details of MB and MS).
The differences of these tests are:
d The test of single-SNP association is to compare MP
with MB (see Table 2 for descriptions of MP and MB).
d The test of associations allowing for interactions is to
compare MS with MB.
d The test of interaction is to compare MS with MH.
strong interactions without displaying significant main effects.The AmericanAs we mentioned above, no closed-form solution exists
for the test of interactions. In this sense, the test of interac-
tions is more difficult than the test of associations allowing
for interactions.On Statistical Epistasis
It is extensively debated to what extent statistical epistasis
implies biological or functional epistasis.4 The statistical
epistasis is exploited in the literature, perhaps because of
the following reasons:
d The definition of statistical epistasis yields an appro-
priate measure for describing biological phenomena
that one locus’s effect on the phenotype depends on
another locus.2 This facilitates mathematical analysis
of epistasis.
d On the basis of the statistical definition, gene-gene
interactions can be connected to Kullback-Leibler
divergence used in the information theory (see Equa-
tion 12) and high-order mutual information in
physics.15 This definitionmay bridge the gap between
the biological understanding and the physical inter-
pretation.
d Compositional epistasis, conceived by Bateson, is
closer to the biological understanding of gene-geneJournal of Human Genetics 87, 325–340, September 10, 2010 335
interactions than statistical epistasis.2 Compositional
epistasis has recently been shown to be empirically
testable via a statistical approach.38 In some cases,
compositional and statistical epistatis are equivalent
to each other.38 Therefore, statistical epistasis can still
provide useful information for biological under-
standing.
Currently, PLINK, INTERSNP, and BOOSTare designed to
test statistical epistasis. We realize that detecting statistical
epistasis in a genome-wide scale is easier than finding
compositional epistasis because the test of compositional
epistasis for each SNP pair requires enumerating all
possible genetic interaction models.2 The detection of
compositional epistasis will be investigated in our future
work.
Conclusion
The large number of SNPs genotyped in genome-wide case-
control studies poses a great computational challenge in
the identification of gene-gene interactions. During the
last few years, there have been fast-growing interests in
developing and applying computational and statistical
approaches to finding gene-gene interactions. In this
paper, we present a method named ‘‘BOOST’’ to address
this problem. Not only is BOOST computationally effi-
cient, it has also shown good statistical power for a wide
spectrum of epistasis models. We have successfully applied
our method to analyze seven data sets from the WTCCC.
Our experimental results demonstrate that interaction
mapping is both computationally and statistically feasible
for hundreds of thousands of SNPs genotyped in thou-
sands of samples.
In this work, we focus mainly on the genome-wide
case-control studies; i.e., the disease phenotype can be
represented as a binary variable. In the current stage, our
method cannot be applied to GWAS involving continuous
phenotypes unless those continuous phenotypes can be
discretized. There are two ways to handle covariates in
our models. If the covariate is discrete or can be discretized,
our method can be directly extended to handle it. If not,
logistic regression can be used in the postprocessing step
to adjust the covariate. In the postprocessing step, the
computational burden of logistic regression is affordable
because the number of selected interactions is limited.
There are some limitations of BOOST with respect to
statistical power. BOOST uses a fixed degree of freedom
(df ¼ 4) to conduct the genotype test. When the con-
tingency table is too sparse due to the low minor allele
frequency, the degree of freedom of the statistical test
should be reduced. To improve the performance of
BOOST, we can first use BOOST to report interactions
with a loose threshold and then use the penalized logistic
regression39 with the adaptive degree of freedom to adjust
these interactions. There are several other issues that we
have not addressed, such as population substructures and336 The American Journal of Human Genetics 87, 325–340, Septembimputation of the missed genotypes. We will investigate
them in our future work.Appendix
Log-Linear models
Here, we briefly describe four log-linear models, including
the homogeneous association model MH, the saturated
model MS, the block independence model MB, and the
partial independence model MP. These four models are
used in the main text. Please see details in Agresti.14
Homogeneous Association Model MH
The homogeneous association model MH factorizes the
joint distribution pijk using the joint distributions of all
pairs. The hypothesis is
HH0 : pijk ¼ jijfikujk (Equation 22)
where jij, 4ik and ujk are some lower-order distributions.
The name ‘‘homogeneous association’’ comes from the
fact that the association between any two of three variables
is the same at all levels of the third variable.14
The homogeneous association model MH is defined as
logmijk ¼ lþ lXpi þ lXqj þ lYk þ lXpXqij þ lXpYik þ lXqYjk
(Equation 23)
Unfortunately, no closed-form expression exists for the
MLE of mijk (denoted as bmHijk) in Equation 23. Iterative
approaches, such as the Newton-Raphson method, are
needed in order to estimate the parameters.
Saturated Model MS
The saturated modelMS defines the joint distribution with
all factors. The saturated log-linear model is
logmijk ¼ lþ lXpi þ lXqj þ lYk þ lXpXqij þ lXpYik þ lXqYjk þ lXpXqYijk
(Equation 24)
The MLE of mijk in Equation 24 is
bmSijk ¼ nijk (Equation 25)
Block Independence Model MB
When the joint distribution cannot be completely factor-
ized, it may be factorized into blocks. The hypothesis is
HB0 : pijk ¼ pij:p::k (Equation 26)
The corresponding log-linear model is
logmijk ¼ lþ lXpi þ lXqj þ lYk þ lXpXqij (Equation 27)
Under this structure, the MLE of mijk is
bmBijk ¼ nij:n::kn (Equation 28)
er 10, 2010
Partial Independence Model MP
The joint distribution may be factorized when some vari-
ables are given. For example, given Y, the hypothesis is
HP0 : pijk ¼
pi:kp:jk
p::k
(Equation 29)
The corresponding log-linear model is
logmijk ¼ lþ lXpi þ lXqj þ lYk þ lXpYik þ lXqYjk (Equation 30)
Then the MLE of mijk is
bmPijk ¼ ni:kn:jkn::k (Equation 31)
Connection between Log-Linear Models and Logistic
Models
For convenience, we use the homogeneous association
model MH as an example to describe the equivalence
between a log-linear model and its corresponding logistic
model. Its logit is
log
P

Y ¼ 1 jXp ¼ i;Xq ¼ j

P

Y ¼ 2 jXp ¼ i;Xq ¼ j

¼ logmij1
mij2
¼ logmij1 logmij2
¼

lþ lXpi þ lXqj þ lY1 þ lXpXqij þ lXpYi1 þ lXqYj1



lþ lXpi þ lXqj þ lY2 þ lXpXqij þ lXpYi2 þ lXqYj2

¼ lY1  lY2 þ lXpYi1  lXpYi2 þ lXqYj1  lXqYj2 
(Equation 32)
The first term is a constant that does not depend on i or j.
The second term depends only on the category i of Xp. The
third term depends only on the category j of Xq. Therefore,
this logit has the following form:
log
P

Y ¼ 1 jXp ¼ i;Xq ¼ j

P

Y ¼ 2 jXp ¼ i;Xq ¼ j

¼ lY1  lY2 þ lXpYi1  lXpYi2 þ lXqYj1  lXqYj2 
¼ b0 þ bXpi þ bXqj
(Equation 33)W ¼ X1
X2
X3
2664
U1 U2 U3 U4 U5 U6 U7 U8 D1 D2 D3 D4 D5 D6 D7 D8
1 3 2 2 3 3 1 1 2 2 3 3 1 2 1 1
3 2 2 2 1 1 1 2 3 3 1 1 1 2 1 2
1 1 3 3 2 2 2 1 1 2 2 2 1 1 1 3
3775Clearly, this is equivalent to the logistic model with only
main effect terms defined in Equation 1. Using the similar
inference mentioned above, it is straightforward to findThe Americanthe connection between the saturated model MS and the
full logistic regression model defined in Equation 2.
Proof of bLS  bLH%bLS  bLKSA
To show this, we need only to show bLHRbLKSA. By Equation
4 and Equation 13, we have
bmKijk ¼ n$bpKijk ¼ nh pij:pi:kp:jkpi::p:j:p::k (Equation 34)
Taking the logarithm on both sides of Equation 34 yields
logbmKijk ¼ ðlogn loghÞ  logpi::  logp:j:  logp::k
þlogpij: þ logpi:k þ logp:jk
¼ lþ lXpi þ lXqj þ lYk þ lXpXqij þ lXpYik
þlXqYjk
(Equation 35)
where
l ¼ logn logh;
l
Xp
i ¼ logpi::; lXqj ¼ logp:j:; lYk ¼ logp::k;
l
XpXq
ij ¼ logpij:; lXpYik ¼ logpi:k; lXqYjk ¼ logp:jk
(Equation 36)
This shows that the KSA model can be written in the
form of Equation 23. For any model with this structure,
we have shown that the log-likelihood LH evaluated at its
MLE bmHijk achieves its maximum bLH in Equation 9. There-
fore, we have
bLH ¼ LHbmHijk ¼ max
mijk
LH

mijk

RLH

mKijk

¼ bLKSA
(Equation 37)
Boolean Representation and Operation of Genotype
Data
For a data set containing L SNPs genotyped from n
samples, an L3n matrix W is usually used to store the
data, where each row represents genotype data for one
specific SNP and each column represents one sample.
A toy example including three SNPs genotyped from 16
samples is illustrated below, where the first eight columns
in W (denoted as Ui) represent control samples and the
others represent case samples (denoted as Di).To evaluate the interaction effect between SNP p and
SNP q, we need two rows (Xp,Xq) inW to collect the contin-
gency table. It is very time consuming to collectJournal of Human Genetics 87, 325–340, September 10, 2010 337
contingency tables for all SNP pairs in a genome-wide case-
control study, because hundreds of billions of SNPs pairs
exist for typical genotyping chips.
In ourmethod, we introduce a Boolean representation of
genotype data. Instead of using one row for each SNP, the
new representation uses three rows, with each row for one
specific genotype. Each row consists of two-bit strings, one
for control samples and the other for case samples. Each bit
in the string represents one sample, and its value (0 or 1)
indicates whether the sample has the corresponding
genotype. For the above toy example, the corresponding
Boolean representation is as follows:
Wbit ¼
X1 ¼ 1
X1 ¼ 2
X1 ¼ 3
X2 ¼ 1
X2 ¼ 2
X2 ¼ 3
X3 ¼ 1
X3 ¼ 2
X3 ¼ 3
2666666666666664
Control
10000011
00110000
01001100
00001110
01110001
10000000
11000001
00001110
00110000
Case
00001011
11000100
00110000
00111010
00000101
11000000
10001110
01110000
00000001
3777777777777775
Both W and Wbit contain the same amount of informa-
tion. To demonstrate this equivalence, we underline
some matched items between W and Wbit. For example,
the five 20s in the first row of W are represented as five 1’s
in the second row of Wbit. Although the dimension of
Wbit is three times as large as that of W, its space usage in
the computer is smaller because each byte can store 8
bits. For a data set with 4000 samples and 500,000 SNPs
(about the same size as the WTCCC data set), the new
data representation needs around 700M bytes, whereas
the general data representation requires 1900M bytes.
More importantly, using Wbit is more CPU efficient than
using W in collecting the contingency table (Table 1).
This is because we can directly carry out the fast logic (bit-
wise) operation with Wbit. For example, to collect n121 in
Table 1 (n121 represents the number of cases with Xq ¼ 1
and Xq ¼ 2), we just need to conduct the logical AND
operation on the case bit strings of row Xp ¼ 1 and
Xq ¼ 2, then count the number of 1’s in the result. The
64-bit registers can perform 64-bit AND operation in one
instruction, and the counting of ‘‘1’’ bits in a bit string
(also called hamming weight) can be accomplished
with an efficient algorithm (see http://en.wikipedia.org/
wiki/Hamming_weight).Genetic Heterogeneity Simulation
The simulation models are chosen on the basis of the
performance of BOOST and PLINK in case 2. For each
setting of h2 and MAF, there are five models. We choose
the one under which BOOST and PLINK perform best
(i.e., have the highest statistical power). For example,
both BOOST and PLINK have the best performance on
model epi33 among models epi31–epi35 (with the same
setting of h2 ¼ 0.05 and MAF ¼ 0.2). Therefore, for this338 The American Journal of Human Genetics 87, 325–340, Septembsetting of h2 and MAF, we select model epi33. The reason
for so doing is to make sure that both BOOST and PLINK
have reasonably good performance when genetic hetero-
geneity is absent. Thenwe can observe how genetic hetero-
geneity degrades their performance. All selectedmodels are
given in Table S5. In the simulation, 100 data sets are
generated under each model setting. In each data set,
1000 SNPs are simulated. Different sample sizes (n ¼ 400,
800, and 1600) are simulated. To simulate genetic hetero-
geneity, 50% case samples are generated at loci X1 and
X2 and another 50% case samples are generated at loci
X3 and X4. The distribution of case samples is based on
a specific disease model given in Table S6. Each data set
has two pairs of associated SNPs. Therefore, there are
200 pairs of SNPs for each parameter setting. We set the
counter T to be zero initially. If one pair of these 200 pairs
is detected (on the basis of the Bonferroni correction), then
T ¼ T þ 1. After testing 100 data sets, the power is calcu-
lated as T/200.
Quality Control
We first check the quality of control samples:
d Those genotype data with a Chiamo score27 < 0.95
are considered as missing data. SNPs with more than
10% missing data are removed.
d Those SNPs with a minor allele frequency < 0.05 are
removed.
d We also perform the Hardy-Weinberg Equilibrium
(HWE) test for each SNP. Those SNPs with a p value%
0.001 are removed.
Next, we check the quality of case samples. The strategy
is similar to that for control samples except that the HWE
test is not performed. The number of remaining SNPs is
given in Table S1.
More Results of T1D Data Analysis
We have identified 91 interactions in which all loci are
nonsignificant in the single-locus scan. These 91 interac-
tions show two interesting interaction patterns between
MHC class I and class II. We have shown one pattern in
the main article. We have also identified another interac-
tion pattern in chromosome 6 in the 31350k–31390k
region (shown in Figure S1) and the 32930k–32960k
region (shown in Figure S2). The six interactions between
these two regions are listed in Table S2. It can be observed
again that all SNPs in this table display weak main effects
whereas their joint effects are statistically significant. We
further report the odds ratios for those interactions in
Table S3 and Table S4. For the first interaction group given
in Table S3, the genotype combinations Aa/Bb, Aa/bb,
aa/Bb, and aa/bb, where the uppercase and lowercase
letters represent the major alleles andminor alleles, respec-
tively, have significantly higher disease risks than others.
The interaction effect of these genotypes can generally
approximate the multiplicative model (see the left paneler 10, 2010
of Figure S3). For the second interaction group given in
Table S4, the genotype combination aa/bb has a signifi-
cantly higher disease risk than others. The interaction
effect of this genotype is considered as a joint recessive
effect (see the right panel of Figure S3).Supplemental Data
Supplemental Data include eight figures and 14 tables and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
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